33 Background 34 Parkinson's disease (PD) is a debilitating neurodegenerative disorder. PD can be treated with deep brain 35 stimulation (DBS) when dopaminergic medication is no longer a viable option. Both treatments are 36 effective in improving motor symptoms, however, their underlying mechanisms are not fully elucidated 37 yet. 38 Objectives 39 To study the effects of DBS and dopaminergic medication treatments on cortical processing and 40 corticomuscular drive during movements. 41 Methods 42 Magnetoencephalography (MEG) was recorded in 10 PD patients and 10 healthy controls, performing 43 phasic hand contractions (hand gripping). Measurements were performed in DBS-treated, untreated and 44 dopaminergic-medicated states; healthy controls received no treatment interventions. Participants 45 performed phasic contractions with their right hand, recorded with electromyography (EMG). Our 46 measures of interest were beta (13-30 Hz) corticomuscular coherence (CMC) and low-gamma (31-45 Hz) 47
whereas dopaminergic medication has been reported to increment beta-CMC to the level of healthy 89 controls (Salenius et al., 2002) . 90
Motor cortical gamma-band activity (>30 Hz), on the other hand, peaks after movement onset 91 (Muthukumaraswamy, 2010; Litvak et al., 2012) and is sustained throughout the movement (Crone et al., 92 1998; Muthukumaraswamy, 2010) and is localized to contralateral motor cortex (Crone et al., 1998) . The 93 literature on the effects of DBS and dopaminergic medication on motor cortical gamma activity is sparse, 94 however, STN gamma-band activity has shown concomitant increase with improved motor symptoms 95 after levodopa administration (Brown et al., 2001; Kühn et al., 2006) . 96
In order to elucidate the effects of treatments on motor cortical oscillations and CMC, we measured 97 magnetoencephalography (MEG) and electromyography (EMG) from PD patients in DBS-treated, 98 untreated and dopaminergic medicated states while they performed phasic contractions (hand gripping). 99
We used hand gripping instead of an isometric wrist extension task (which is often used in experiments 100 on movement related oscillatory activity) to better exemplify daily activities such as grasping a cup or 101 picking up an object than an isometric task and thereby increase the ecological validity of the target task. 102
We focused on CMC in the beta band (13-30 Hz), which has been consistently shown for both phasic 103 movements and isometric wrist extensions (Kilner et (Major Depression Inventory). A total of two patients were excluded from the study for reasons 118 extraneous to the exclusion criteria: one patient could not tolerate the DBS OFF conditions while the other 119 had a corrupt EMG channel in one condition and hence did not pass the data quality check. The remaining 120 participant cohorts thus consisted of 10 PD patients (age: 60 ±1.7 (SEM); 5 female) and 10 age-matched 121 healthy controls (age: 58.3 ±1.3 (SEM); 3 female). See Tab. 1 for all relevant demographic and clinical 122 details on the two cohorts. 123 head shape were then used to co-register the participants' MEG data and structural MRIs for source 148 localization. The head position measurements in the MEG system were not possible during the DBS ON 149 condition due to interference from the electrical stimulation with the HPIs. We therefore used the head 150 position measurement from the subsequent recording after switching off DBS and before the patient had 151 been taken out of the MEG system (and thus potentially changed his or her position). 152
Data preprocessing

153
The data was first processed using the tSSS algorithm implemented in Maxfilter (Taulu and Simola, 2006) 154 to suppress DBS artefacts and other external magnetic artifacts (subspace correlation limit: 0.9, time 155 window: 10s (Medvedovsky et al., 2009) ) and this approach has already been shown to successfully 156 suppress DBS artefacts (Airaksinen et al., 2011 (Airaksinen et al., , 2012 (Airaksinen et al., , 2015b (Airaksinen et al., , 2015a Sridharan et al., 2017) and other 157 magnetic interferences (Taulu et al., 2005; Taulu and Simola, 2006; Taulu and Hari, 2009 ). All data (MEG, 158 EMG, EOG and ECG) were bandpass filtered between 1-100 Hz using a two-pass second order Butterworth 159
filter. An ICA-based artefact rejection routines to suppress ECG-and EOG-related artefacts was 160 implemented using the MNE-Python toolbox (Gramfort et al., 2013) . All subsequent analyses of the pre-161 processed data were carried out using the Fieldtrip toolbox (Oostenveld et al., 2011) as implemented in 162 MATLAB (The MathWorks Inc., Natick, MA, 2000). Data were epoched into 1-second segments around the 163 peaks of the gripping action. To obtain the peaks, EMG data were Hilbert-transformed and the absolute 164 value was computed to obtain the power envelope after which they were standardized. These 165 standardized envelopes were visually inspected to define thresholds for peaks in each condition which 166 were then used to automatically epoch the data. This epoching procedure rendered and average of 91±5 167 (SEM) epochs in the PD and 97±2 in the control cohort (see Tab. 2 for condition-wise details). 168
Sensor analysis
169
Power and cross spectral densities (PSD & CSD) between MEG and EMG data were computed using the 170 multitaper method (Mitra and Pesaran, 1999) with discrete prolate spheroidal sequences (DPSS) as tapers, as implemented in Fieldtrip. The central frequencies were 1 to 100 Hz with a bandwidth of 1 Hz. The mean 172 squared coherence was then obtained from the CSD to reflect corticomuscular coherence (CMC). The 173 maxima of the orthogonal gradiometer pairs were used in the case of coherence while the sums of the 174 gradiometer values were used for combining gradiometer pairs for power values. To evaluate the motor 175 output, we computed the mean of the trial-wise root mean square (RMS) which reflects the mean motor 176 output in each condition. 177
The PSDs were normalized by dividing the PSD spectra by the total power from the range of 1-45 Hz and 178 z-scoring them. We restricted our spectral analysis to below 45 Hz in order not to confound our analyses 179 with potential DBS artefacts from its first sub-harmonics (i.e. at 65-90 Hz depending on individual 180 stimulation frequency). We defined 15 gradiometer pairs in the left (contralateral) sensorimotor area as 181 the sensors of interest (SOI). We defined two a priori frequency bands of interest: beta (13-30 Hz) and 182 low-gamma (31-45 Hz). We inspected any artefactual peaks in the PSD (due to DBS) and dropped those 183 particular frequency bins from further analysis (see Supplementary material, as well as Airaksinen et al., 184 (2012) , for a similar approach). We obtained summary values for beta-CMC and low-gamma power by 185 searching for maxima in each of the frequency bands in the SOI. The peak frequencies for each subject, 186 condition and measure were passed on to the source localization procedure. 187 188 We performed statistics on patient and control cohorts separately with the control cohort mainly serving 189 to account for potential time-related effects (since counter-balancing the conditions was not possible in 190 our experimental design). We used Bayesian inferencing given by Bayes Factors ( In each cohort, we estimated the effect of Condition by modelling a null hypothesis (H0) with only subject-196 specific offsets as random effects against an unconstrained alternative hypothesis (H1) with Condition as 197 fixed effect and subject-specific offsets as random effects. Hypothesis testing moved progressively 198 towards more constraints and comparing the BFs for each of these equality-constrained hypotheses 199 enabled us to obtain meaningful model-driven statistical inferences on the data. We first framed a more 200 constrained hypothesis (H2) to test the three treatment states against each other. We accomplished this 201 by equating DBS OFF (0 min) and DBS OFF (120 min) while allowing DBS ON and MED ON to vary freely. 202
Statistical analysis
We proceed with testing the specific hypotheses, explained below, only if both H1/H0 and H2/H0 showed 203 substantial evidence for the alternative hypothesis. 204
In order to assess whether only one treatment state stood out from the other two, we tested four specific 205 hypotheses with further equality constraints: ( (2016) where the Bayesian inference for correlations in nonparametric data is made on the test statistic 219 in order to obtain BFs. The resulting BFs for Kendall's tau reflect the relative likelihoods of the observed 220 data under the alternative hypothesis (H1) that the modelled slope for the relationship between the two 221 variables (e.g. beta-CMC and UPDRS-III) is non-zero against the null hypothesis (H0) that the slope is zero. 222
We computed BFs for five correlations: (i, ii) beta-CMC vs UPDRS-III and UPDRS-III bradykinesia (right 223 hand) sub-scores (items: 23 to 25 in the UPDRS scoring manual) in the MED ON condition; (iii, iv) low-224 gamma power vs. UPDRS-III and UPDRS-III bradykinesia in the DBS ON condition; and (v) EMG-RMS values 225 vs UPDRS-III scores across all conditions. 226
Source reconstruction 227
Based on our observed effects of dopaminergic medication on beta-CMC and of DBS on low-gamma 228 power, we performed source localization only of those two measures in the two treatment conditions, 229 respectively, using beamforming. T1-weighted structural magnetic resonance images (MRI) were acquired 230 for all controls, and we used the pre-operative MRIs for the PD patients. The co-registration of the MEG 231 data and structural MRIs was performed using the fiducials and head shape points recorded during the 232
MEG acquisition. 233
Each subject's structural MRI was segmented and the inner skull volume was non-linearly warped to a 234 canonical MRI included in SPM8 (http://www.fil.ion.ucl.ac.uk/spm/software/spm8/) and canonical source 235 model inverse was warped to obtain the subject-specific beamformer grid (spacing of 5 mm) making it 236 comparable across subjects and in correspondence with the specific grid points in the Montreal 237 Neurological Institute (MNI) space (Mattout et al., 2007) . The leadfields were computed for each 238 participant and each condition using the single-shell head model based on the individual MRIs of the 239 participants (Nolte, 2003) . 240
Source localization was performed using the Dynamic Imaging of Coherent Sources (DICS) method to 241 localize both beta-CMC and low-gamma power (Gross et al., 2001) . In the case of beta-CMC, the recorded 242 EMG channel was used as a reference for the source localization procedure. In the case of low-gamma 243 power, we used the neural activity index (NAI). As already stated, we used the peak frequencies of the 244 beta-CMC and low-gamma power for each subject and condition to focus the source localization. We set 245 the regularization to 5% for beta-CMC and 0% for low-gamma power. 246
For visualization purposes, we grand-averaged the beta-CMC and low-gamma power source data in the 247 MED ON and DBS ON conditions, respectively, interpolated and plotted them on a canonical volumetric 248 MRI (Colin 27 brain-1mm resolution) with a threshold of 90%. We used the AAL atlas (Automated 249 Anatomical Labelling; Tzourio-Mazoyer et al., 2002), as integrated into the Fieldtrip toolbox, as our 250 anatomical reference and in order to obtain MNI coordinates. 251 
Results
252
UPDRS-III
EMG-RMS
269
The mean of the EMG-RMS of both cohorts are plotted in Fig. 2 (summary values Tab. 2). Evaluation of 270 the unconstrained hypothesis (H1) showed that the EMG-RMS was 177 times (BF10=177.38) more likely to 271 arise from this hypothesis with Condition as a factor compared to the hypothesis without (H0). This is 272 considered very strong evidence (Kass and Raftery, 1995) and suggests an effect of Condition on EMG-273
RMS. 274
In evaluation of the specific hypotheses H3-6, we obtained the highest BF for H5 where DBS ON and MED 275 ON as well as DBS OFF (0 min) and DBS OFF (120 min) were equated. The data were 3.3 times (BF51=3.33) 276 more likely to occur under H5 compared to the unconstrained hypothesis (H1). This is considered positive 277 evidence (Kass and Raftery, 1995) The group means and the grand averaged topographies of beta-CMC are shown in Fig. 3a . The grand 284 averages of the beta-CMC showed relatively focal effects in a few sensors over the contralateral 285 sensorimotor area (See Fig. 3b ). The grand-averaged coherence spectra based on the sensor that captured 286 the maximal beta-CMC is shown in Fig. 3c . The grand-averaged spectra and the spectra at the individual 287 level showed no artefactual peaks due to DBS. Evaluating the effects of treatments on beta-CMC revealed 288 that the beta-CMC data were 3.5 times (BF10=3.45) more likely to arise from the hypothesis containing 289
Condition as a factor and specified as the three treatment states (H1) compared to the null hypothesis 290 without Condition as a factor (H0). This is considered positive evidence (Kass and Raftery, 1995) suggesting 291 an effect of treatment on beta-CMC. 292
On evaluating the specific hypotheses (H3-6), we found the highest BF for H3 where DBS ON, DBS OFF (0 293 min), DBS OFF (120 min) are equated and only MED ON is allowed to differ. The beta-CMC data were 14.2 294 times (BF30=14.23) more likely to arise from this hypothesis compared to the null hypothesis (H0) and 2 295 times (BF32=2.06) more likely to arise from the specific hypothesis H3 compared to the constrained 296 hypothesis (H2). Both BF30 and BF20 are considered positive evidence (Kass and Raftery, 1995) and since 297 BF30 is the higher of the two, it indicates that the MED ON condition was different from the other three 298 conditions and thus that dopaminergic medication affects beta-CMC. The corresponding BFs for the 299 Controls showed evidence for the null hypothesis, i.e., no effects of Condition (or Time, see Tab. 3). 300
Power 301 Fig. 4a shows the group means and grand-averaged topographies of low-gamma power. In the DBS ON 302 condition in the PD patients, the low-gamma power showed a focus in activity in sensors over the 303 contralateral sensorimotor area ( Fig. 4b ), quite similar in distribution to the beta-CMC. The grand-304 averaged power spectra based on the sensor that captured the maximal low-gamma power is shown in 305 Fig. 4c . Individual power spectra showed subject-specific artefactual frequency bins within the frequency 306 range of interest, which were dropped from the analysis (see Methods). Evaluating the effect of treatment 307 on low-gamma power estimated that the data were 3,105 times (BF20=3,104.68) more likely to occur 308 under the hypothesis with Condition as a factor and with the DBS OFF (0 min) and DBS OFF (120 min) 309 equated (H2) compared to the null hypothesis. This is considered very strong evidence (Kass and Raftery, 310 1995) suggesting an effect of treatment on low-gamma power. Evaluation of the specific hypotheses (H3-311 6) revealed that the low-gamma power data were 6728 times (BF40=6727.95) more likely to occur under 312 the hypothesis where DBS OFF (0 min), DBS OFF (120 min) and MED ON are equated (H4) compared to the null hypothesis (H0). This is considered very strong evidence (Kass and Raftery, 1995) and suggests that 314 the low-gamma power is different in the DBS-treated condition compared to the other three conditions 315 and thus an effect of DBS on movement-related low-gamma power. The corresponding BFs for the 316 Controls showed evidence for the null hypothesis and thus suggest no effects of Condition (or Time, see 317
Tab. 3). 318
In order to rule out any potential effects in the DBS ON condition due to confounds from sub-harmonics 319 and interference from the electrical stimulation (at 130 Hz), we conducted a parallel sham-analysis for 320 low-gamma power with 15 gradiometer pairs over the right (ipsilateral) hemisphere and with a set of 8 321 gradiometer pairs over the occipital region. Low-gamma summary values obtained from the right and 322 occipital SOIs did not show any modulation by the treatments, thereby confirming that the increase in 323 low-gamma power in DBS ON over the sensorimotor area is very unlikely to be an artefact of the electrical 324 stimulation (see Supplementary material). We also correlated the DBS voltage levels for the patients' left 325 and right hemispheres with their observed low-gamma power over the contralateral sensorimotor area 326 as a further test for potential confounds from the electrical stimulation (See Correlations). 327
Correlations 328 UPDRS-bradykinesia (right-hand) sub-scores correlated with the beta-CMC in the MED ON condition 329 (BF10=3.83; τ=-0.57), suggesting that the observed data were 3.8 times more likely to occur under the 330 alternative (H1) than under the null hypothesis (H0). The overall UPDRS-III scores did not show any 331 substantial evidence for the data under the alternative or the null hypothesis (BF10=1.86; τ=-0.47). While 332 the former BF (UPDRS-bradykinesia) is considered positive evidence, the latter BF (UPDRS-III) denotes 333 evidence barely worth a mention (Kass and Raftery, 1995) . The low-gamma power was not correlated with 334 the overall UPDRS-III scores (BF10=0.63; τ=-0.26) or the UPDRS-bradykinesia (right-hand) sub-scores 335 (BF10=0.59; τ=0.24). The BFs suggest that the observed relationships between the low-gamma power and 336 the UPDRS-III and UPDRS-bradykinesia scores were 1.6 and 1.7 times more likely to occur under the null hypothesis (H0) with zero slope, respectively. Neither BFs are considered more than evidence barely worth 338 a mention (Kass and Raftery, 1995) . 339
The UPDRS-III scores correlated with the motor output as measured by EMG-RMS (BF10=132.75; 340 τ =-0.41). The BF suggests that the observed data were 133 times more likely to occur under the 341 alternative hypothesis (H1) with non-zero slope than under the null hypothesis (H0) with zero slope. This 342 is considered very strong evidence (Kass and Raftery, 1995) . 343
For the potentially confounding correlations between DBS voltage levels and low-gamma power, we did 344 not find any substantial evidence for or against the data under the null or the alternative hypotheses. showing similar ameliorating effects on the motor symptoms in PD patients. Dopaminergic medication 361 augments beta-CMC (13-30 Hz) in PD patients (localized to contralateral precentral gyrus) while DBS 362 increases low-gamma (31-45 Hz) spectral power (also localized to contralateral precentral gyrus). 363 hand gripping task, as it has been shown that CMC varies depending on the nature of the task (Kilner et 380 al., 2000) . Our results are contrary to results which show beta-CMC is not affected by dopaminergic 381 medication (Hirschmann et al., 2013) , it is important to note that the experiment in said report were 382 performed with subcutaneous apomorphine medication, and although it has a very short half-life and was 383 stopped two hours before experiment, residual subcutaneous apomorphine may have confounded the 384 finding. So we compliment the results previously reported by eradicating the potentially confounding 385 effect of concomitant medication and extend the results already reported by Salenius et al. (2002) by 386 incorporating a DBS ON condition. 387
Mechanism of dopaminergic medication on beta-CMC and motor symptoms
In rat models, dopamine has been shown to affect local circuits and the cortical interneuron activity which 388 in turn affects the pyramidal neuron activity . 389 Dopaminergic medication could influence the direct and indirect pathways in the cortico-basal ganglia 390 circuitry by binding to the dopaminergic receptors (D1 and D2) in striatum (Surmeier et al., 2007) . These 391 two results are indicative of the influence of dopamine on striatal input to the basal ganglia and pyramidal-392 interneuron interplay and eventually on the corticomuscular drive. Moreover, beta-CMC increases have 393 been shown to improve performance Witte et al., 2007) , and the increase we 394 observe may thus be a compensatory mechanism to improve the recalibration process and reduce errors 395 during movements as part of the overall improvement in motor action caused by dopaminergic 396 medication in PD patients. 397 potentially modulates the cortical low-gamma oscillations through its effects on the basal ganglia-cortical 420 functional network via the "hyperdirect pathway". 421
Mechanism of DBS on low-gamma power and motor symptoms
However, we note that the present study was performed with a modest cohort of 10 PD patients and 10 422 healthy controls, and the evidence for our observed treatment effects on movement related cortical 423 oscillations are moderate in nature and thus necessitate studies with larger cohorts to ensure the 424 potential reproducibility of the results. 425
In conclusion, we have shown differentiated effects of DBS and dopaminergic medication on cortical 426 activity during phasic hand contractions. While both treatments affect motor symptoms similarly, each of 427 the treatments may employ different functional modulation strategies through differentiated anatomical 428 pathways in their improvement of the motor output. Low-gamma power in the occipital region across the four conditions. The plot shows no substantial 508 differences in low-gamma power in the occipital region between treatments. This suggests that the 509 increased low-gamma power in the DBS ON condition is a localized effect over the sensorimotor area and 510 that it is not due to corruption from sub-harmonics of the DBS artefacts. 511
Supp. Tab. ST1: Bayes Factors for the sham analyses: Bayes Factors for the corresponding alternative 512
hypotheses against the null for the sham SOIs, namely, the right hemisphere and the occipital area. 513
Evaluation of the hypothesis (H1) revealed that the low-gamma power data was more likely to occur under 514 the null hypothesis compared to the alternative hypothesis with Conditions as factor (H1). This is 515 considered positive evidence (Kass and Raftery, 1995) and suggests that the low-gamma power was not 516 substantially different between conditions and thus no noticeable effect of DBS treatment on movement-517 related low-gamma power over the right hemisphere and over the occipital area. This confirms that the 518 increase in low-gamma power in DBS ON over the left sensorimotor area is very unlikely to be an artefact 519 of the electrical stimulation. 520 
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